Drug-eluting vs. conventional balloon for side branch dilation in coronary bifurcations treated by provisional T stenting

Journal of Interventional Cardiology

Volumn 26, Issue 5, 2013, Pages 454-462

  Herrador, Juan A ^a   Fernandez, Juan C ^a   Guzman, Manuel ^a   Aragon, Victor ^a  

^a Servicio de Cardiologia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PACLITAXEL; SEQUENT; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ANGIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BALLOON DILATATION; COMPARATIVE STUDY; CORONARY BIFURCATION LESION; DRUG ELUTING BALLOON; DRUG ELUTING STENT; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTRAVENOUS UROGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; STENTS; TREATMENT OUTCOME;

EID: 84885397008     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/joic.12061     Document Type: Article

References (23)

1. Pan M, Suárez de Lezo J, Medina A, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy. Am Heart J 2004; 148: 857-864.
2. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249.
3. Colombo A, Bramucci E, Saccà S, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study. Circulation 2009; 119 (1): 71-78.
4. Steigen TK, Maeng M, Wiseth R., et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic bifurcation study. Circulation 2006; 114 (18): 1955-1961.
5. Hildick-Smith D, de Belder A, Cooter N, et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions. The British Bifurcation Coronary Study: Old, New, and Evolving Strategies. Circulation 2010; 121: 1235-1243.
6. Hoye A, Van Mieghem C, Ong AT, et al. Clinical and angiographic outcomes following crush bifurcation stenting with drug-eluting stents: Low target lesion revascularization rates but high rate of side-branch restenosis in the absence of kissing balloon after dilatation. Circulation 2004; 110: 757.
7. Nasu K, Oikawa Y, Yoshikawa R., et al. A randomized comparison of sirolimus- vs. paclitaxel-eluting stents for treatment of bifurcation lesions by single stent and kissing balloon: Results of the SINGLE KISS trial. Int J Cardiol 2013; 166: 187-192.
8. Fanggiday JC, Stella PR, Guyomi SH, et al. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: The DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Catheter Cardiovasc Interv 2008; 71 (5): 629-635.
9. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006; 355: 2113-2124.
10. Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009; 119 (23): 2986-2994.
11. Medina A, Suarez de Lezo J, Pan M., A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006; 59: 183.
12. Thygesen K, Alpert JS, Jaffe AS., et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33 (20): 2551-2567.
13. Cutlip DE, Windecker S, Mehran R., et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
14. Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating: A novel method for prevention and therapy of restenosis. Circulation 2004; 110: 810-814.
15. Unverdorben M, Kleber FX, Heuer H, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010; 99: 165-174.
16. Mathey DG, Wendig I, Boxberger M, et al. Treatment of bifurcation lesions with a drug-eluting balloon: The PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention 2011; 7 (Suppl K): K61-K65.
17. Belkacemi A, Agostoni P, Voskuil M, et al. Coronary bifurcation lesions treated with the drug-eluting balloon: A preliminary insight from the DEBIUT study. EuroIntervention 2011; 7 (Suppl K): K66-K69.
18. Bondesson P, Lagerqvist B, James SK, et al. Comparison of two drug-eluting balloons: A report from the SCAAR registry. EuroIntervention 2012; 8 (4): 444-449.
19. Stone G, Rizvi A, Newman W, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease, for the SPIRIT IV Investigators. N Engl J Med 2010; 362: 1663-1674.
20. Herrador JA, Fernandez JC, Guzman M, et al. Comparison of zotarolimus- versus everolimus-eluting stents in the treatment of coronary bifurcation lesions. Catheter Cardiovasc Interv 2011; 78 (7): 1086-1092.
21. Brunel P, Lefevre T, Darremont O, et al. Provisional T-stenting and kissing balloon in the treatment of coronary bifurcation lesions: Results of the French multicenter "TULIPE" study. Catheter Cardiovasc Interv 2006; 68 (1): 67-73.
22. Ferenc M, Gick M, Kienzle RP, et al. Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J 2008; 29 (23): 2859-2867.
23. Pan M, Medina A, Suárez de Lezo J, et al. Coronary bifurcation lesions treated with simple approach (from the Cordoba & Las Palmas [CORPAL] Kiss Trial). Am J Cardiol 2011; 107 (10): 1460-1465.